Table 2.
Patient/FSHR Mutation * |
Puberty | Amenorrhea | Ovary | Ovarian Histology | Receptor Function In Vitro |
---|---|---|---|---|---|
Paris 1 a/Pro519Thr | Delayed | Primary | Hypoplasic | ↑Primordial and primary follicles | Total loss of function |
Finnish 1 b/Ala189Val | Delayed | Primary | Hypoplasic | ↓Primordial; ↓secondary rare mature follicles | c-AMP: ∼29% of WT FSHR; IP3: almost totally lost |
Paris 2 c/Asp224Val, Leu601Val | Normal | Primary | Normal | Primordial, primary, secondary and antral follicles up to 3 mm diameter | c-AMP: ∼4% and 12% of WT FSHR |
Paris 3 d/Ile160Thr, Arg573Cys | Normal | Secondary | Normal | Primordial, primary, secondary and antral follicles up to 5 mm diameter | c-AMP: ∼9% and 24% of WT FSHR |
Animal model | |||||
FSHR KO mice e | Hypoplasic | Primordial, primary, secondary follicles | Total inactivation |